There appears to be one with phaze 1 (completed?) looking for funding. I would imagine huge amounts of funding might have been harder to get before this became an issue with a heightened public profile. Still don't see this becoming a cash cow for anyone, unless there is a fad to get vaccinated among billionaires or something.

55% seems optimistic. Not sure if hantavirus has any legs

@Bandors oh man wrong thread what happened here

Here's a version targeted at the current outbreak, but less stringent requirements and less ambitious timeline:

I know you're copying Polymarket, but the focus on FDA is pretty weird: it only makes sense assuming there's a pandemic. If not, we could see an increased interest in hantavirus vaccines, but I'd expect them to be initially tested and approved in the regions where the various hantaviruses are naturally occurring (especially Argentina and Chile, home to the Andes virus as it is the cause of the MV Hondius outbreak). The US has very few domestic cases of their local hantaviruses.

Similarly to how hantavax is approved in China (which has high loads of hantavirus infections) but there's little interest in seeking approval elsewhere as other countries don't have the same load of its target hantaviruses (Hantaan virus, Seoul virus)

@AIBear I agree the resolution criteria is funky... Polymarket seems to miss the mark with this sorta stuff surprisingly often. Put this market up primarily because seeing the discrepancy on here vs. PM is pretty interesting to track